Abstract
A facile and versatile procedure has been explored for the synthesis of 2-amino-5-oxo-5,6,7,8-tetrahydro-4Hchromenes, pyrano[2,3-d]pyrimidines and 1,4-dihydropyrano[2,3-c]pyrazole-5-yl cyanides. This protocol employs the one-pot three-component condensation of aromatic aldehydes and malononitrile with 5,5-dimethyl-cyclohexane-1,3- dione, 1,3-dimethyl barbituric acid or 3-methyl-1-phenyl-2-pyrazolin-5-ones respectively in ethanol under the catalytic effect of triethylamine and ultrasonic-irradiation conditions. Simple manipulation, high reaction rates, improved yields, use of inexpensive and non-toxic catalyst, and also use of ethanol as a relatively environmentally benign solvent are the main advantages of this protocol.
Keywords: 4H-chromenes, pyrano[2, 3-d]pyrimidines, pyrano[2, 3-c]pyrazole, ultrasonic-irradiation, triethylamine, scaffolds, antibronchitics, microwave, electrochemically, induced
Letters in Organic Chemistry
Title:Ultrasonic-Promoted One-Pot Synthesis of 4H-chromenes, pyrano[2,3- d]pyrimidines, and 4H-pyrano[2,3-c]pyrazoles
Volume: 9 Issue: 6
Author(s): Davood Azarifar, Razieh Nejat-Yami, Fatemeh Sameri and Zahra Akrami
Affiliation:
Keywords: 4H-chromenes, pyrano[2, 3-d]pyrimidines, pyrano[2, 3-c]pyrazole, ultrasonic-irradiation, triethylamine, scaffolds, antibronchitics, microwave, electrochemically, induced
Abstract: A facile and versatile procedure has been explored for the synthesis of 2-amino-5-oxo-5,6,7,8-tetrahydro-4Hchromenes, pyrano[2,3-d]pyrimidines and 1,4-dihydropyrano[2,3-c]pyrazole-5-yl cyanides. This protocol employs the one-pot three-component condensation of aromatic aldehydes and malononitrile with 5,5-dimethyl-cyclohexane-1,3- dione, 1,3-dimethyl barbituric acid or 3-methyl-1-phenyl-2-pyrazolin-5-ones respectively in ethanol under the catalytic effect of triethylamine and ultrasonic-irradiation conditions. Simple manipulation, high reaction rates, improved yields, use of inexpensive and non-toxic catalyst, and also use of ethanol as a relatively environmentally benign solvent are the main advantages of this protocol.
Export Options
About this article
Cite this article as:
Azarifar Davood, Nejat-Yami Razieh, Sameri Fatemeh and Akrami Zahra, Ultrasonic-Promoted One-Pot Synthesis of 4H-chromenes, pyrano[2,3- d]pyrimidines, and 4H-pyrano[2,3-c]pyrazoles, Letters in Organic Chemistry 2012; 9 (6) . https://dx.doi.org/10.2174/157017812801322435
DOI https://dx.doi.org/10.2174/157017812801322435 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Stability in Cognitive Function Over 18 Years: Prevalence and Predictors among Older Mexican Americans
Current Alzheimer Research Inhibition of Matrix Metalloproteinases (MMPs) as a Potential Strategy to Ameliorate Hypertension-Induced Cardiovascular Alterations
Current Drug Targets Interplay between RNA Methylation Eraser <i>FTO</i> and Writer <i>METTL3</i> in Renal Clear Cell Carcinoma Patient Survival
Recent Patents on Anti-Cancer Drug Discovery COVID-19 and Autoimmune Diseases: A Systematic Review of Reported Cases
Current Rheumatology Reviews Editorial [Hot topic: Sleep Abnormalities in Pulmonary Disease (Guest Editor: Shyamsunder Subramanian)]
Current Respiratory Medicine Reviews Role of Inflammatory Cells and Toll-Like Receptors in Atherosclerosis
Current Vascular Pharmacology The Adult Patient with Eisenmenger Syndrome: A Medical Update after Dana Point Part III: Specific Management and Surgical Aspects
Current Cardiology Reviews Neuroinflammation and Immunity: A New Pharmacological Target in Depression
CNS & Neurological Disorders - Drug Targets Meet Our Editorial Board Member
Current Aging Science Glycoxidation of Low Density Lipoprotein in Impaired Glucose Tolerance: Implications for the Pathogenesis of Diabetic Vascular Disease
Vascular Disease Prevention (Discontinued) FDG-PET Scanning Shows Distributed Changes in Cortical Activity Associated with Visual Hallucinations in Eye Disease
Endocrine, Metabolic & Immune Disorders - Drug Targets Active Coatings: Examples and Applications
Recent Patents on Mechanical Engineering Co-administration of Phycocyanobilin and/or Phase 2-Inducer Nutraceuticals for Prevention of Opiate Tolerance
Current Pharmaceutical Design How to Assess Sympathetic Nervous System Activity in Clinical Practice
Current Clinical Pharmacology Efficient Vessel Segmentation Based on Proposed Adaptive Conditional Random Field Model
Recent Advances in Computer Science and Communications The Incidence of Adverse Drug Reactions in Patients Treated with Statins in the Emirates: A Retrospective Cohort Study
Current Vascular Pharmacology Medical Therapy of Aortic Aneurysms: A Pathophysiology-Based Approach
Current Vascular Pharmacology Pigment Epithelium-Derived Factor: A Novel Therapeutic Target for Cardiometabolic Diseases and Related Complications
Current Medicinal Chemistry Structure and Inhibitor Binding Mechanisms of 11β -Hydroxysteroid Dehydrogenase Type 1
Current Chemical Biology Perspective Design of Chalcones for the Management of CNS Disorders: A Mini-Review
CNS & Neurological Disorders - Drug Targets